NicholasFidelmanMD

Radiology • San Francisco, CA

Interventional Neuroradiology, Vascular & Interventional Radiology

Assistant Professor, Radiology, UCSF School of Medicine

Join to view full profile

Dr. Fidelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fidelman's full profile

Already have an account?

Office
505 Parnassus Avenue, Box 0628
Ucsf Department Of Radiology
San Francisco, CA 94143
Phone+1 415-353-1000

Fax+1 415-476-0616

Education & Training

University of California (San Francisco)Residency, Radiology-Diagnostic, 2003 - 2007
St Mary's Hospital and Medical CenterInternship, Internal Medicine, 2002 - 2003
University of California San Francisco School of MedicineClass of 2002

Certifications & Licensure

CA State Medical License 2003 - 2025
American Board of Radiology Interventional Radiology and Diagnostic Radiology

Clinical Trials

Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma Start of enrollment: 2010 May 01
Terminated
Not Applicable
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases Start of enrollment: 2010 May 01
Completed
Phase 2
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
Completed
Not Applicable
TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve Start of enrollment: 2014 Dec 17
Terminated
Not Applicable
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases Start of enrollment: 2017 Jan 09
Completed
Phase 1
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases Start of enrollment: 2018 Aug 27
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.
Mishal Mendiratta-Lala, Anum Aslam, Harrison X Bai, Julius Chapiro, Thiery De Baere
European Radiology. 2024-05-01
Intra-arterial Peptide Receptor Radionuclide Therapy for the Treatment of Hepatic Neuroendocrine Tumor Metastases: Hope or Hype?
Michael V Khanjyan, Nicholas Fidelman
Seminars in Interventional Radiology. 2024-02-01
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant.
Xiao Wu, Allison Kwong, Michael Heller, R Peter Lokken, Nicholas Fidelman
Liver Transplantation. 2024-02-01

Lectures

Phase I prospective trial of TAS-102 (trifluride and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
WOMEN’S IMAGING IN WINE COUNTRY NAPA, CALIFORNIA
UCSF - Helen Diller Family Comprehensive Cancer Center, Napa, California - 9/29/2013
WOMEN’S IMAGING IN WINE COUNTRY NAPA, CALIFORNIA
UCSF - Helen Diller Family Comprehensive Cancer Center, Napa, California - 9/29/2013

Press Mentions

Breaking the Boundaries Between Radiology and Oncology: GU Oncology Profiles Thomas a. Hope, MDApril 28th, 2022
K. Pallav Kolli, MD, Appointed Chief of Interventional RadiologyOctober 18th, 2021
Recognizing the Role of Nurses in the Growth of Radiology Services at UCSFMay 7th, 2021
Join now to see all

Professional Memberships

Society of Interventional Radiology - SIR
Member